Individual RNA-seq for different prostate cancer cells, tumors treated by LGK974, ENZ, EPZ6438, EED226 or by CTNNB1 gene knockdown and overexpression, and BRN2 gene knockdown
RNA-seq (gene expression) · mouse · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 36 samples: 36 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE294887_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1251980 and SRA study SRP579395. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 36 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8927681 42D, siControl for siCTNNB1
- GSM8927682 42D, siCTNNB1
- GSM8927683 42D, Vehicle for LGK974
- GSM8927684 42D, 10uM LGK974
- GSM8927685 42D, Vehicle for EPZ,GSK, EED226
- GSM8927686 42D, 10uM EPZ6438
- GSM8927687 42D, 10uM GSK126
- GSM8927688 42D, 10uM EED226
- GSM8927689 35CR, Vehicle
- GSM8927690 35CR, LGK974
- GSM8927691 35CR, EPZ6438
- GSM8927692 35CR, ENZ
- GSM8927693 35CR, ENZ+EPZ
- GSM8927694 35CR, EPZ+LGK
- GSM8927695 35ENZR
- GSM8927696 C42B, siControl for siCTNNB1, 48 hours
- GSM8927697 C42B, siCTNNB1, 48 hours
- GSM8927698 C42B, empty, 48 hours
- GSM8927699 C42B, empty siBRN2, 48 hours
- GSM8927700 C42B, oe-CTNNB1,48 hours
- GSM8927701 C42B, oe-CTNNB1, siBRN2, 48 hours
- GSM8927702 C42B, Vehicle for EPZ, GSK, EED226
- GSM8927703 C42B, 10uM EPZ6438
- GSM8927704 C42B, 10uM GSK126
- GSM8927705 C42B, 10uM EED226
- GSM8927706 LNCaP, Vehicle for EPZ, PF, EED226
- GSM8927707 LNCaP, 10uM EPZ6438
- GSM8927708 LNCaP, 10uM PF
- GSM8927709 LNCaP, 10uM EED226
- GSM8927710 LNCaP, vehicle for 42d
- GSM8927711 MyC-CaP, Vehicle
- GSM8927712 MyC-CaP, LGK974
- GSM8927713 MyC-CaP, EPZ6438
- GSM8927714 MyC-CaP, ENZ
- GSM8927715 MyC-CaP, ENZ+EPZ
- GSM8927716 MyC-CaP, EPZ+LGK
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.